Artisan Mid Cap Fund Q1 2026 Commentary [Seeking Alpha]
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Our underweight to financials contributed positively, particularly in capital markets, where the industry declined double digits during the quarter. Among our top contributors in Q1 were Comfort Systems, Twist Bioscience and RBC Bearings. Our biggest detractors were DoorDash, MongoDB and Roblox. Love Employee/iStock via Getty Images Portfolio Management Matt Kamm, CFA Portfolio Manager (Co-Lead) Jason White, CFA Portfolio Manager (Co-Lead) Jim Hamel, CFA Portfolio Manager Angela Wu Portfolio Manager Jay Warner, CFA Portfolio Manager Investing Environment Global equities declined during This article was written by Quick Insights ARTMX outperformed the Russell Midcap Growth Index on a relative basis, aided by strong stock selection in industrials and health care, despite negative absolute returns. The fund is positioned for continued growth in health care, AI-driven infrastructure, and aerospace/defense, leveraging secular trends and company-specif
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience (TWST) had its "overweight" rating reaffirmed by Barclays PLC.MarketBeat
- Twist Bioscience (TWST) had its price target raised by Guggenheim from $50.00 to $55.00. They now have a "buy" rating on the stock.MarketBeat
- Twist Bioscience (TWST) had its "sell (d-)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Assessing Twist Bioscience (TWST) Valuation After Insider Sale And Recent Q1 FY26 Optimism [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Adds Invenra Bispecific Platform To Broaden Discovery Opportunity [Yahoo! Finance]Yahoo! Finance
TWST
Earnings
- 2/2/26 - Miss
TWST
Sec Filings
- 4/16/26 - Form 4
- 4/14/26 - Form 144
- 4/13/26 - Form 4
- TWST's page on the SEC website